HomeInsightsStock Comparison

Godavari Drugs Ltd vs Gujarat Terce Laboratories Ltd Stock Comparison

Godavari Drugs Ltd vs Gujarat Terce Laboratories Ltd Stock Comparison

Last Updated on: May 19, 2025

Key Highlights

  • The Latest Trading Price of Godavari Drugs Ltd is ₹ 96.4 as of 19 May 11:16.
  • The P/E Ratio of Godavari Drugs Ltd changed from 4.3 on March 2020 to 12.6 on March 2024 . This represents a CAGR of 23.99% over 5 yearsThe P/E Ratio of Gujarat Terce Laboratories Ltd changed from 17.1 on March 2020 to 160.4 on March 2024 . This represents a CAGR of 56.47% over 5 years.
  • The Market Cap of Godavari Drugs Ltd changed from ₹ 8.7 crore on March 2020 to ₹ 69.99 crore on March 2024 . This represents a CAGR of 51.74% over 5 yearsThe Market Cap of Gujarat Terce Laboratories Ltd changed from ₹ 4.7 crore on March 2020 to ₹ 39.29 crore on March 2024 . This represents a CAGR of 52.91% over 5 years.
  • The revenue of Godavari Drugs Ltd for the Dec '24 is ₹ 29.65 crore as compare to the Sep '24 revenue of ₹ 26.1 crore. This represent the growth of 13.6% The revenue of Gujarat Terce Laboratories Ltd for the Dec '24 is ₹ 12.75 crore as compare to the Sep '24 revenue of ₹ 13.38 crore. This represent the decline of -4.71%.
  • The ebitda of Godavari Drugs Ltd for the Dec '24 is ₹ 2.68 crore as compare to the Sep '24 ebitda of ₹ 2.91 crore. This represent the decline of -7.9% The ebitda of Gujarat Terce Laboratories Ltd for the Dec '24 is ₹ 1.16 crore as compare to the Sep '24 ebitda of ₹ 1.74 crore. This represent the decline of -33.33%.
  • The net profit of Godavari Drugs Ltd changed from ₹ 0.81 crore to ₹ 0.77 crore over 7 quarters. This represents a CAGR of -2.85% The net profit of Gujarat Terce Laboratories Ltd changed from ₹ -1.31 crore to ₹ 1.01 crore over 7 quarters. This represents a CAGR of NaN% .
  • The Dividend Payout of Godavari Drugs Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Gujarat Terce Laboratories Ltd changed from 0 % on March 2020 to 0 % on March 2024 . This represents a CAGR of 0.0% over 5 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Godavari Drugs Ltd

  • Godavari Drugs Limited is engaged in the business of manufacture of Active Pharmaceutical Ingredients (API) and drug intermediates, through its manufacturing facility at Nanded, Maharashtra, India..
  • Sulphamethoxazole (SMX), the main product of the company, is a widely used anti-bacterial drug enjoying good export demand. The Company incorporated in December, 1987, has multiple production blocks for API's, drug intermediates and fine chemicals. The company has expanded its SMX capacity from 540 tpa to 720 tpa, integrating backward into the manufacture of drug intermediates, sulphamethoxide (cap.: 450 tpa) and diethyl oxalate, DEO (cap.: 750 tpa), and diversifying into the manufacture of trimetroprim, TMP (cap.: 144 tpa). The diversification into TMP is beneficial as SMX and TMP are used in combination to treat a wide variety of infections.

About Gujarat Terce Laboratories Ltd

  • Gujarat Terce Laboratories Limited, incorporated in 1985, produces branded generic formulations for the domestic market.
  • Over its more than three-decade business journey, the Company developed an extensive product basket comprising 50 brands covering multiple therapeutic areas which are marketed by its 180+ strong MR team across 13 Indian states.
  • Headquartered in Ahmedabad, the Company has its fully automated facility at Chhatral, in Gandhinagar, Gujarat By 1986, Terce had established its presence in Gujarat and Rajasthan with a firm footing.
  • In 1992, the management raised public equity to give concrete shape and listed the Company on Bombay Stock Exchange.
  • In same year, Company established extensive manufacturing facility at Chhatral in Gandhinagar, Gujarat.

Godavari Drugs Ltd News Hub

News

Godavari Drugs to declare Quarterly Results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 12 February...

Read more

07 Feb 2025 15:41

News

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 November...

Read more

09 Nov 2024 11:59

News

Godavari Drugs to discuss results

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 14 August 2...

Read more

10 Aug 2024 11:12

News

Godavari Drugs to conduct AGM

Godavari Drugs announced that the 36th Annual General Meeting (AGM) of the company will be...

Read more

28 Jun 2024 18:50

News

Godavari Drugs to convene board meeting

Godavari Drugs will hold a meeting of the Board of Directors of the Company on 30 May 2024...

Read more

29 May 2024 13:53

News

Godavari Drugs revises board meeting date

Godavari Drugs has revised the meeting of the Board of Directors which was scheduled to be...

Read more

08 Feb 2024 12:02

Gujarat Terce Laboratories Ltd News Hub

News

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

27 Jan 2025 14:03

News

Gujarat Terce Laboratories to declare Quarterly Result

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

18 Oct 2024 17:17

News

Gujarat Terce Laboratories to convene AGM

Gujarat Terce Laboratories announced that the Annual General Meeting (AGM) of the company ...

Read more

20 Aug 2024 16:03

News

Gujarat Terce Laboratories to conduct board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

03 Aug 2024 17:01

News

Gujarat Terce Laboratories schedules board meeting

Gujarat Terce Laboratories will hold a meeting of the Board of Directors of the Company on...

Read more

22 May 2024 14:31

News

Gujarat Terce Laboratories to hold EGM

Gujarat Terce Laboratories announced that an Extra Ordinary General Meeting (EGM) of the C...

Read more

30 Mar 2024 19:37

SWOT Analysis Of Godavari Drugs Ltd

Strength

2

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

SWOT Analysis Of Gujarat Terce Laboratories Ltd

Strength

1

S

Weakness

2

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Godavari Drugs Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Gujarat Terce Laboratories Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Godavari Drugs Ltd and Gujarat Terce Laboratories Ltd

Which company has a larger market capitalization, Godavari Drugs Ltd or Gujarat Terce Laboratories Ltd?

Market cap of Godavari Drugs Ltd is 71 Cr while Market cap of Gujarat Terce Laboratories Ltd is 42 Cr

What are the key factors driving the stock performance of Godavari Drugs Ltd and Gujarat Terce Laboratories Ltd?

The stock performance of Godavari Drugs Ltd and Gujarat Terce Laboratories Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Godavari Drugs Ltd and Gujarat Terce Laboratories Ltd?

As of May 19, 2025, the Godavari Drugs Ltd stock price is INR ₹94.66. On the other hand, Gujarat Terce Laboratories Ltd stock price is INR ₹57.12.

How do dividend payouts of Godavari Drugs Ltd and Gujarat Terce Laboratories Ltd compare?

To compare the dividend payouts of Godavari Drugs Ltd and Gujarat Terce Laboratories Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions